
|Articles|August 11, 2008
Cystoid macular oedema drug begins testing
IBI-20089, a drug candidate for the treatment of cystoid macular oedema (CME), has completed patient enrollment for initial clinical testing, according to the drug's manufacturer, Icon Bioscience Inc (IBI).
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement


















